{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:33:41Z","timestamp":1762252421822,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T00:00:00Z","timestamp":1473724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jare.2016.09.004","type":"journal-article","created":{"date-parts":[[2016,9,17]],"date-time":"2016-09-17T16:16:17Z","timestamp":1474128977000},"page":"931-944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["In silico identification of T-type calcium channel blockers: A ligand-based pharmacophore mapping approach"],"prefix":"10.1016","volume":"7","author":[{"given":"Tamanna","family":"Gandhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anu R.","family":"Melge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gopi Mohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2016.09.004_b0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fphys.2015.00153","article-title":"Selectivity filters and cysteine-rich extracellular loops in voltage-gated sodium,calcium, and NALCN channels","volume":"6","author":"Stephens","year":"2015","journal-title":"Front Physiol"},{"key":"10.1016\/j.jare.2016.09.004_b0010","first-page":"126","article-title":"Neuronal T-type calcium channels: what\u2019s new? Iftinca: T-type channel regulation","volume":"4","author":"Iftinica","year":"2011","journal-title":"J Med Lif"},{"key":"10.1016\/j.jare.2016.09.004_b0015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1124\/pr.57.4.5","article-title":"International union of pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels","volume":"57","author":"Catterall","year":"2005","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jare.2016.09.004_b0020","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00424-014-1444-z","article-title":"T-type calcium channels blockers as new tools in cancer therapies","volume":"466","author":"Dziegielewska","year":"2014","journal-title":"Eur J Phys"},{"key":"10.1016\/j.jare.2016.09.004_b0025","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00424-008-0582-6","article-title":"Ca2+ signaling by T-type Ca2+ channels in neurons","volume":"457","author":"Cueni","year":"2009","journal-title":"Eur J Phys"},{"key":"10.1016\/j.jare.2016.09.004_b0030","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1016\/j.bmcl.2007.08.070","article-title":"Discovery of potent T-type calcium channel blocker","volume":"17","author":"Seo","year":"2007","journal-title":"Biorg Med Chem Lett"},{"key":"10.1016\/j.jare.2016.09.004_b0035","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.2174\/138161206777585184","article-title":"The role of T-type calcium channels in epilepsy and pain","volume":"12","author":"Nelson","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jare.2016.09.004_b0040","first-page":"707","article-title":"Linking calcium channel variants to potential therapies","volume":"9","author":"Belardetti","year":"2008","journal-title":"Curr Opin Invest Drugs"},{"key":"10.1016\/j.jare.2016.09.004_b0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1152\/physrev.00018.2002","article-title":"Molecular physiology of low-voltage-activated t-type calcium channels","volume":"83","author":"Perez-Reyes","year":"2003","journal-title":"Physio Rev"},{"key":"10.1016\/j.jare.2016.09.004_b0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1517\/13543776.2011.536532","article-title":"T-type calcium channels inhibitors: a patent review","volume":"21","author":"Giordanetto","year":"2011","journal-title":"Exp Opin Therap Patents"},{"key":"10.1016\/j.jare.2016.09.004_b0055","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1021\/acsmedchemlett.5b00023","article-title":"Optimization of ADME properties for sulfonamides leading to the discovery of aT-type calcium channelblocker, ABT-639","volume":"28","author":"Zhang","year":"2015","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.jare.2016.09.004_b0060","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/jpet.108.145672","article-title":"Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs","volume":"328","author":"Perez-Reyes","year":"2009","journal-title":"J Pharmacol Expt Therap"},{"key":"10.1016\/j.jare.2016.09.004_b0065","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1016\/j.bmcl.2004.04.090","article-title":"3,4-Dihydro-quinazoline derivatives as novel selective T-type Ca2+ channel blockers","volume":"14","author":"Lee","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jare.2016.09.004_b0070","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.bmc.2004.01.034","article-title":"First pharmacophoric hypothesis for T-type calcium channel blockers","volume":"12","author":"Doddareddy","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.jare.2016.09.004_b0075","first-page":"125","article-title":"Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A","volume":"28","author":"Bennett","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jare.2016.09.004_b0080","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/pr.112.007336","article-title":"Computational methods in drug discovery","volume":"66","author":"Gregory","year":"2014","journal-title":"Pharmacol Rev"},{"issue":"11","key":"10.1016\/j.jare.2016.09.004_b0085","first-page":"444","article-title":"Pharmacophore modeling and applications in drug discovery: challenges and recent advances","volume":"15","author":"Sheng","year":"2010","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jare.2016.09.004_b0090","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ardp.201500045","article-title":"Generated 3D-common feature hypotheses using the HipHop method for developing new topoisomerase I inhibitors","volume":"348","author":"Sanaz","year":"2015","journal-title":"Arch Pharm Chem Life Sci"},{"issue":"34","key":"10.1016\/j.jare.2016.09.004_b0095","first-page":"80","article-title":"Pharmacophore mapping based inhibitor selection and molecular interaction studies for identification of potential drugs on calcium activated potassium channel blockers tamulotoxin","volume":"9","author":"Barani","year":"2013","journal-title":"Pharmaco Mag"},{"issue":"5","key":"10.1016\/j.jare.2016.09.004_b0100","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3109\/14756360903393817","article-title":"A common feature-based 3D-pharmacophore model generation and virtual screening: identification of potential PfDHFR inhibitors","volume":"25","author":"Adane","year":"2010","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.jare.2016.09.004_b0105","unstructured":"Catalyst version4.10, A. I., S.R., San Diego, CA, USA; 2005."},{"key":"10.1016\/j.jare.2016.09.004_b0110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jcc.540160205","article-title":"Poling: promoting conformational variation","volume":"16","author":"Smellie","year":"1995","journal-title":"J Comput Chem"},{"key":"10.1016\/j.jare.2016.09.004_b0115","unstructured":"Accelrys Inc, S. R., San Diego, CA, USA. In Cerius2 version4.10."},{"key":"10.1016\/j.jare.2016.09.004_b0120","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.bmcl.2006.10.024","article-title":"Synthesis and biological evaluation of novel T-type calcium channel blockers","volume":"17","author":"Choi","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jare.2016.09.004_b0125","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1016\/j.bmc.2006.01.005","article-title":"Synthesis and SAR studies of a novel series of T-type calcium channel blockers","volume":"15","author":"Park","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jare.2016.09.004_b0130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bmcl.2004.10.078","article-title":"Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers","volume":"15","author":"Rhim","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jare.2016.09.004_b0135","unstructured":"SYBYL7.1; Tripos Inc., S. L., MO 63144 USA."},{"key":"10.1016\/j.jare.2016.09.004_b0140","doi-asserted-by":"crossref","first-page":"22799","DOI":"10.3390\/molecules201219880","article-title":"Pharmacophore models and pharmacophore-based virtual screening: concepts and applications exemplified on hydroxysteroid dehydrogenases","volume":"20","author":"Teresa","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.jare.2016.09.004_b0145","doi-asserted-by":"crossref","first-page":"e1293","DOI":"10.1038\/cddis.2014.250","article-title":"Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening","volume":"5","author":"Liu","year":"2014","journal-title":"Cell Death Disease"},{"key":"10.1016\/j.jare.2016.09.004_b0150","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.1039\/C6CC01079B","article-title":"Structure-based screening and optimization of cytisine derivatives as inhibitors of the menin\u2013MLL interaction","volume":"52","author":"Zhong","year":"2016","journal-title":"Chem Commun"},{"issue":"15","key":"10.1016\/j.jare.2016.09.004_b0155","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1016\/j.bmc.2015.06.005","article-title":"In vitro evaluation and in silico screening of synthetic acetylcholinesterase inhibitors bearing functionalized piperidine pharmacophores","volume":"23","author":"Brahmachari","year":"2015","journal-title":"Bioorg Med Chem"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123216300728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123216300728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:42:03Z","timestamp":1761856923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123216300728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S2090123216300728"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2016.09.004","relation":{},"ISSN":["2090-1232"],"issn-type":[{"type":"print","value":"2090-1232"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico identification of T-type calcium channel blockers: A ligand-based pharmacophore mapping approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2016.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Production and hosting by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}